Histone H1 recruitment by CHD8 is essential for suppression of the Wnt-β-catenin signaling pathway

Molecular and Cellular Biology

Volumn 32, Issue 2, 2012, Pages 501-512

  Nishiyama, Masaaki ^a,b   Skoultchi, Arthur I ^c   Nakayama, Keiichi I ^a,b  

^a KYUSHU UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AXIN; AXIN 2; BETA CATENIN; CHROMODOMAIN HELICASE DNA BINDING PROTEIN 8; DNA BINDING PROTEIN; HISTONE H1; MESSENGER RNA; MYC PROTEIN; PROTEIN P53; UNCLASSIFIED DRUG; WNT PROTEIN;

ARTICLE; CHROMATIN; EMBRYO DEVELOPMENT; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSACTIVATION; UPREGULATION; WNT SIGNALING PATHWAY;

ANIMALS; BETA CATENIN; BINDING SITES; CELL LINE; DNA-BINDING PROTEINS; GENE EXPRESSION; GENE EXPRESSION REGULATION; HISTONES; HUMANS; MICE; MUTATION; TRANSCRIPTION FACTORS; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84856803144     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.06409-11     Document Type: Article

References (47)

1. Barker N, et al. 2001. The chromatin remodelling factor Brg-1 interacts with beta-catenin to promote target gene activation. EMBO J. 20: 4935-4943.
2. Bienz M, Clevers H. 2000. Linking colorectal cancer to Wnt signaling. Cell 103:311-320.
3. Billin AN, Thirlwell H, Ayer DE. 2000. β-Catenin-histone deacetylase interactions regulate the transition of LEF1 from a transcriptional repressor to an activator. Mol. Cell. Biol. 20:6882- 6890.
4. Cohen ED, Tian Y, Morrisey EE. 2008. Wnt signaling: an essential regulator of cardiovascular differentiation, morphogenesis and progenitor self-renewal. Development 135:789 -798.
5. Daniels DL, Weis WI. 2005. Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation. Nat. Struct. Mol. Biol. 12:364 -371.
6. Fan Y, et al. 2005. Histone H1 depletion in mammals alters global chromatin structure but causes specific changes in gene regulation. Cell 123: 1199-1212.
7. Flanagan JF, et al. 2005. Double chromodomains cooperate to recognize the methylated histone H3 tail. Nature 438:1181-1185.
8. Funayama R, Saito M, Tanobe H, Ishikawa F. 2006. Loss of linker histone H1 in cellular senescence. J. Cell Biol. 175:869-880.
9. Graham TA, Weaver C, Mao F, Kimelman D, Xu W. 2000. Crystal structure of a β-catenin/Tcf complex. Cell 103:885- 896.
10. Happel N, Doenecke D. 2009. Histone H1 and its isoforms: contribution to chromatin structure and function. Gene 431:1-12.
11. He TC, et al. 1998. Identification of c-MYC as a target of the APC pathway. Science 281:1509 -1512.
12. He X, Semenov M, Tamai K, Zeng X. 2004. LDL receptor-related proteins 5 and 6 in Wnt/β-catenin signaling: arrows point the way. Development 131:1663-1677.
13. Hurd EA, et al. 2007. Loss of Chd7 function in gene-trapped reporter mice is embryonic lethal and associated with severe defects in multiple developing tissues. Mamm. Genome 18:94 -104.
14. Ishihara K, Oshimura M, Nakao M. 2006. CTCF-dependent chromatin insulator is linked to epigenetic remodeling. Mol. Cell 23:733-742.
15. Kamura T, et al. 2004. VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases. Genes Dev. 18:3055-3065.
16. -/- colon carcinoma. Science 275: 1784-1787.
17. Kramps T, et al. 2002. Wnt/wingless signaling requires BCL9/leglessmediated recruitment of pygopus to the nuclear β-catenin-TCF complex. Cell 109:47- 60.
18. Lever MA, Th'ng JP, Sun X, Hendzel MJ. 2000. Rapid exchange of histone H1.1 on chromatin in living human cells. Nature 408:873- 876.
19. Menon T, Yates JA, Bochar DA. 2010. Regulation of androgenresponsive transcription by the chromatin remodeling factor CHD8. Mol. Endocrinol. 24:1165-1174.
20. Misteli T, Gunjan A, Hock R, Bustin M, Brown DT. 2000. Dynamic binding of histone H1 to chromatin in living cells. Nature 408:877- 881.
21. Moon RT, Kohn AD, De Ferrari GV, Kaykas A. 2004. WNT and β-catenin signalling: diseases and therapies. Nat. Rev. Genet. 5:691-701.
22. Morin PJ, et al. 1997. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275:1787-1790.
23. Morita S, Kojima T, Kitamura T. 2000. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7:1063-1066.
24. Mosimann C, Hausmann G, Basler K. 2006. Parafibromin/Hyrax activates Wnt/Wg target gene transcription by direct association with β-catenin/Armadillo. Cell 125:327-341.
25. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707-720.
26. Kip1, polyploidy and centrosome overduplication. EMBO J. 19:2069 -2081.
27. Nelson WJ, Nusse R. 2004. Convergence of Wnt, β-catenin, and cadherin pathways. Science 303:1483-1487.
28. Nishiyama M, et al. 2004. Early embryonic death in mice lacking the β-catenin-binding protein Duplin. Mol. Cell. Biol. 24:8386-8394.
29. Nishiyama M, et al. 2009. CHD8 suppresses p53-mediated apoptosis through histone H1 recruitment during early embryogenesis. Nat. Cell Biol. 11:172-182.
30. Oshima M, et al. 1995. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc. Natl. Acad. Sci. U. S. A. 92:4482- 4486.
31. Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e45.
32. Rodenberg JM, et al. 2010. Regulation of serum response factor activity and smooth muscle cell apoptosis by chromodomain helicase DNAbinding protein 8. Am. J. Physiol. Cell Physiol. 299:C1058 -1067.
33. Rodriguez-Paredes M, Ceballos-Chavez M, Esteller M, Garcia-Dominguez M, Reyes JC. 2009. The chromatin remodeling factor CHD8 interacts with elongating RNA polymerase II and controls expression of the cyclin E2 gene. Nucleic Acids Res. 37:2449-2460.
34. Roose J, et al. 1998. The Xenopus Wnt effector XTcf-3 interacts with Groucho-related transcriptional repressors. Nature 395:608-612.
35. Rubinfeld B, et al. 1997. Stabilization of β-catenin by genetic defects in melanoma cell lines. Science 275:1790 -1792.
36. Sakamoto I, et al. 2000. A novel β-catenin-binding protein inhibits betacatenin-dependent Tcf activation and axis formation. J. Biol. Chem. 275: 32871-32878.
37. Sampietro J, et al. 2006. Crystal structure of a β-catenin/BCL9/Tcf4 complex. Mol. Cell 24:293-300.
38. Schnetz MP, et al. 2009. Genomic distribution of CHD7 on chromatin tracks H3K4 methylation patterns. Genome Res. 19:590-601.
39. Sierra J, Yoshida T, Joazeiro CA, Jones KA. 2006. The APC tumor suppressor counteracts β-catenin activation and H3K4 methylation at Wnt target genes. Genes Dev. 20:586-600.
40. Sims RJ, 3rd, et al. 2007. Recognition of trimethylated histone H3 lysine 4 facilitates the recruitment of transcription postinitiation factors and pre-mRNA splicing. Mol. Cell 28:665- 676.
41. Thompson BA, Tremblay V, Lin G, Bochar DA. 2008. CHD8 is an ATP-dependent chromatin remodeling factor that regulates β-catenin target genes. Mol. Cell. Biol. 28:3894 -3904.
42. Vissers LE, et al. 2004. Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat. Genet. 36:955-957.
43. Willert K, et al. 2003. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423:448-452.
44. Willert K, Jones KA. 2006. Wnt signaling: is the party in the nucleus? Genes Dev. 20:1394 -1404.
45. Yates JA, Menon T, Thompson BA, Bochar DA. 2010. Regulation of HOXA2 gene expression by the ATP-dependent chromatin remodeling enzyme CHD8. FEBS Lett. 584:689-693.
46. Yuan CC, et al. 2007. CHD8 associates with human Staf and contributes to efficient U6 RNA polymerase III transcription. Mol. Cell. Biol. 27: 8729-8738.
47. Zhang Y, LeRoy G, Seelig HP, Lane WS, Reinberg D. 1998. The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities. Cell 95:279 -289.